A detailed history of Bailard, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Bailard, Inc. holds 145,430 shares of JNJ stock, worth $21.2 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
145,430
Previous 147,863 1.65%
Holding current value
$21.2 Million
Previous $23.2 Million 0.74%
% of portfolio
0.64%
Previous 0.69%

Shares

37 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$155.22 - $162.74 $377,650 - $395,946
-2,433 Reduced 1.65%
145,430 $23 Million
Q4 2023

Feb 02, 2024

SELL
$145.6 - $158.88 $438,838 - $478,864
-3,014 Reduced 2.0%
147,863 $23.2 Million
Q3 2023

Oct 24, 2023

BUY
$155.75 - $174.48 $2.77 Million - $3.1 Million
17,789 Added 13.37%
150,877 $23.5 Million
Q2 2023

Jul 20, 2023

BUY
$154.35 - $166.11 $221,492 - $238,367
1,435 Added 1.09%
133,088 $22 Million
Q1 2023

May 08, 2023

SELL
$151.05 - $180.26 $51,054 - $60,927
-338 Reduced 0.26%
131,653 $20.4 Million
Q4 2022

Feb 02, 2023

BUY
$160.2 - $179.79 $51,424 - $57,712
321 Added 0.24%
131,991 $23.3 Million
Q3 2022

Oct 18, 2022

SELL
$161.33 - $179.52 $19,359 - $21,542
-120 Reduced 0.09%
131,670 $21.5 Million
Q2 2022

Jul 27, 2022

BUY
$168.19 - $186.01 $1.97 Million - $2.18 Million
11,700 Added 9.74%
131,790 $23.4 Million
Q1 2022

Apr 25, 2022

BUY
$158.14 - $179.59 $52,502 - $59,623
332 Added 0.28%
120,090 $21.3 Million
Q4 2021

Feb 10, 2022

SELL
$155.93 - $173.01 $154,838 - $171,798
-993 Reduced 0.82%
119,758 $20.5 Million
Q3 2021

Nov 15, 2021

BUY
$161.5 - $179.47 $48,773 - $54,199
302 Added 0.25%
120,751 $19.5 Million
Q2 2021

Aug 13, 2021

SELL
$159.48 - $171.07 $314,494 - $337,350
-1,972 Reduced 1.61%
120,449 $19.8 Million
Q1 2021

May 13, 2021

BUY
$153.07 - $170.48 $2.89 Million - $3.22 Million
18,890 Added 18.25%
122,421 $20.1 Million
Q4 2020

Feb 03, 2021

SELL
$137.11 - $157.38 $138,618 - $159,111
-1,011 Reduced 0.97%
103,531 $16.3 Million
Q3 2020

Nov 10, 2020

BUY
$140.38 - $153.83 $96,019 - $105,219
684 Added 0.66%
104,542 $15.6 Million
Q2 2020

Aug 12, 2020

BUY
$128.81 - $155.51 $278,100 - $335,746
2,159 Added 2.12%
103,858 $14.6 Million
Q1 2020

Apr 16, 2020

BUY
$111.14 - $153.99 $624,940 - $865,885
5,623 Added 5.85%
101,699 $13.3 Million
Q4 2019

Jan 31, 2020

BUY
$127.5 - $146.44 $571,582 - $656,490
4,483 Added 4.89%
96,076 $14 Million
Q3 2019

Oct 18, 2019

SELL
$126.95 - $142.14 $186,743 - $209,087
-1,471 Reduced 1.58%
91,593 $11.9 Million
Q2 2019

Jul 26, 2019

SELL
$131.15 - $144.24 $342,957 - $377,187
-2,615 Reduced 2.73%
93,064 $13 Million
Q1 2019

Apr 24, 2019

SELL
$125.72 - $139.79 $168,087 - $186,899
-1,337 Reduced 1.38%
95,679 $13.4 Million
Q4 2018

Feb 05, 2019

BUY
$122.84 - $147.84 $29,604 - $35,629
241 Added 0.25%
97,016 $12.5 Million
Q3 2018

Nov 13, 2018

SELL
$121.58 - $142.88 $136,777 - $160,740
-1,125 Reduced 1.15%
96,775 $13.4 Million
Q2 2018

Aug 08, 2018

SELL
$119.4 - $131.76 $133,250 - $147,044
-1,116 Reduced 1.13%
97,900 $11.9 Million
Q1 2018

May 07, 2018

BUY
$125.1 - $148.14 $326,010 - $386,052
2,606 Added 2.7%
99,016 $12.7 Million
Q4 2017

Feb 08, 2018

SELL
$131.22 - $143.62 $242,757 - $265,697
-1,850 Reduced 1.88%
96,410 $0
Q3 2017

Oct 11, 2017

BUY
$129.47 - $135.38 $125,974 - $131,724
973 Added 1.0%
98,260 $12.8 Million
Q2 2017

Aug 11, 2017

BUY
N/A
2,239 Added 2.36%
97,287 $0
Q1 2017

Jan 29, 2018

SELL
N/A
-1,964 Reduced 2.02%
95,048 $11.8 Million
Q4 2016

Jan 29, 2018

BUY
N/A
1,218 Added 1.27%
97,012 $0
Q3 2016

Jan 29, 2018

BUY
N/A
26,176 Added 37.6%
95,794 $11.3 Million
Q2 2016

Jan 29, 2018

BUY
N/A
33,803 Added 94.38%
69,618 $0
Q1 2016

Jan 29, 2018

BUY
N/A
690 Added 1.96%
35,815 $3.88 Million
Q3 2015

Jan 29, 2018

SELL
N/A
-636 Reduced 1.78%
35,125 $3.28 Million
Q2 2015

Jan 29, 2018

SELL
N/A
-5,038 Reduced 12.35%
35,761 $0
Q1 2015

Jan 29, 2018

BUY
N/A
600 Added 1.49%
40,799 $4.1 Million
Q4 2014

Jan 29, 2018

BUY
N/A
40,199
40,199 $0

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $380B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Bailard, Inc. Portfolio

Follow Bailard, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bailard, Inc. with notifications on news.